​Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 21, Sarah James from Cantor Fitzgerald reiterated a Buy rating on Elevance Health, Inc. (NYSE:ELV) with a price target of $400. ​The firm maintains a cautious outlook on the 2026 Medicaid Environment, noting that the company has conservative elements in its 2026 earnings per share projections. In addition, the firm also believes that execution in Medicare Advantage, commercial business, and Carel ...